Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 12Gynecologic 5Head & Neck 4Genitourinary 4Thoracic 3Other 2Endocrine 2Tumor-Agnostic 1Sarcoma 1Other neoplasm 1NET 1Breast 1

Conditions

Gastrointenstinal Stromal Tumor (GIST) 1

Interventions

Radiotherapy 215Cyclophosphamide 210Doxorubicin 207Temozolomide 181Ifosfamide 121Filgrastim 111Etoposide 101Imatinib Mesylate 99Vincristine 92Gemcitabine 89Bevacizumab 83Irinotecan 79Magnetic Resonance Spectroscopy 78pembrolizumab 75Radiation 66Carboplatin 65pazopanib 60Methotrexate 60Nivolumab 58Cisplatin 58fludarabine phosphate 56Peripheral Blood Stem Cell Transplantation 56Specimen Handling 53Docetaxel 50Busulfan 48Trabectedin 47Biopsy 47Melphalan 46Surgical Procedures, Operative 44Paclitaxel 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Robotic Surgical Procedures × Sarcoma × Clear all
NCT07405125 2026-02-12

Safety of Robotic Surgery for GISTs at Special Anatomic Sites

The First Affiliated Hospital with Nanjing Medical University

Phase NA Recruiting
182 enrolled
Sarcoma

Gastrointenstinal Stromal Tumor (GIST)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡